Cargando…
Deubiquitylating enzyme USP9x regulates radiosensitivity in glioblastoma cells by Mcl-1-dependent and -independent mechanisms
Glioblastoma is a very aggressive form of brain tumor with limited therapeutic options. Usually, glioblastoma is treated with ionizing radiation (IR) and chemotherapy after surgical removal. However, radiotherapy is frequently unsuccessful, among others owing to resistance mechanisms the tumor cells...
Autores principales: | Wolfsperger, F, Hogh-Binder, S A, Schittenhelm, J, Psaras, T, Ritter, V, Bornes, L, Huber, S M, Jendrossek, V, Rudner, J |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4816183/ https://www.ncbi.nlm.nih.gov/pubmed/26775694 http://dx.doi.org/10.1038/cddis.2015.405 |
Ejemplares similares
-
Protein Levels of Anti-Apoptotic Mcl-1 and the Deubiquitinase USP9x Are Cooperatively Upregulated during Prostate Cancer Progression and Limit Response of Prostate Cancer Cells to Radiotherapy
por: Hogh-Binder, Sophia A., et al.
Publicado: (2023) -
USP4 Auto-Deubiquitylation Promotes Homologous Recombination
por: Wijnhoven, Paul, et al.
Publicado: (2015) -
Deubiquitylating enzymes and disease
por: Singhal, Shweta, et al.
Publicado: (2008) -
Deubiquitylating enzyme USP9x regulates hippo pathway activity by controlling angiomotin protein turnover
por: Thanh Nguyen, Hung, et al.
Publicado: (2016) -
Role of the Deubiquitylating Enzyme DmUsp5 in Coupling Ubiquitin Equilibrium to Development and Apoptosis in Drosophila melanogaster
por: Kovács, Levente, et al.
Publicado: (2015)